Correction to: Multicenter phase II study of trastuzumab plus S-1 alone in elderly patients with HER2-positive advanced gastric cancer (JACCRO GC‑06)

Affiliations

• ¹ Department of Surgery, Kindai University Faculty of Medicine, Osaka-Sayama, Japan.
• ² Japan Clinical Cancer Research Organization, 7F Ginza Wing Building, 1-14-5, Ginza, Chuo-ku, Tokyo, 104-0061, Japan. [email protected].
• ³ Department of Clinical Oncology, Aichi Cancer Center Hospital, Nagoya, Japan.
• ⁴ Department of Surgery, Osaka National Hospital, Osaka, Japan.
• ⁵ Department of Surgery, Gastroenterological Center, Yokohama City University, Yokohama, Japan.
• ⁶ Department of Gastroenterology, Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Tokyo, Japan.
• ⁷ Department of Medical Oncology, Saitama Medical University International Medical Center, Hidaka, Japan.
• ⁸ Aizawa Comprehensive Cancer Center, Aizawa Hospital, Matsumoto, Japan.
• ⁹ First Department of Surgery, Dokkyo Medical University Hospital, Tochigi, Japan.
• ¹⁰ Department of Surgery, Gifu Prefectural General Medical Center, Gifu, Japan.
• ¹¹ Department of Medical Oncology, Kobe City Medical Center General Hospital, Kobe, Japan.
• ¹² Department of Surgery, Tokushima Red Cross Hospital, Tokushima, Japan.
• ¹³ Department of Surgery, Fukuyama City Hospital, Fukuyama, Japan.
• ¹⁴ Department of Clinical Medicine (Biostatistics), Kitasato University School of Pharmacy, Tokyo, Japan.
• ¹⁵ Japan Clinical Cancer Research Organization, 7F Ginza Wing Building, 1-14-5, Ginza, Chuo-ku, Tokyo, 104-0061, Japan.